Search

everythinglearnresearchcommunity

for

Search:↓

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Oral minoxidil is effective for various hair loss types and may improve male sexual function, but aspirin can reduce its effectiveness.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Finasteride may help treat chronic CSC, improving vision.

Nanotechnology improves minoxidil treatment for hair loss.

Finasteride effectively stops hair loss in most patients, but concerns about rare sexual side effects exist.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Finasteride may cause slight depression and anxiety.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

People with alopecia have a higher risk of thyroid cancer.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Testosterone's muscle-building effects do not require its conversion to DHT.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.